Sleep and quality of life in restless legs syndrome

Sleep and Quality of Life in Clinical Medicine

Volumn , Issue , 2008, Pages 101-106

  Zucconi, Marco ^a   Manconi, Mauro ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

insomnia; periodic leg movements; quality of life; Restless legs syndrome; sleep; therapy

Indexed keywords

EID: 80051526735     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-60327-343-5_11     Document Type: Chapter

References (40)

1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4(2):101-119.
2. Desautels A, Michaud M, Montplaisir J, Turecki G, Rouleau GA. Restless leg syndrome arousal: clinic, etiology and genetic perspectives. Rev Neurol (Paris) 2002; 158(12):1225-1231.
3. Abetz L, Allen R, Follet A, Washburn T, Earley C, Kirsch J et al. Evaluating the quality of life of patients with restless legs syndrome. Clin Ther 2004; 26(6):925-935.
4. Pearson VE, Allen RP, Dean T, Gamaldo CE, Lesage SR, Earley CJ. Cognitive deficits associated with restless legs syndrome (RLS). Sleep Med 2006; 7(1):25-30.
5. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997; 12(1):61-65.
6. Montplaisir J, Boucher S, Gosselin A, Poirier G, Lavigne G. Persistence of repetitive EEG arousals (K-Alpha complexes) in RLS patients treated with L-DOPA. Sleep 1996; 19(3):196-199.
7. Sateia MJ, Doghramji K, Hauri PJ, Morin CM. Evaluation of chronic insomnia. An American Academy of Sleep Medicine review. Sleep 2000; 23(2):243-308.
8. Allen RP. Article reviewed: the influence of sex, age and sleep/wake state on characteristics of periodic leg movements in restless leg syndrome patients. Sleep Med 2000; 1(2):151-153.
9. Trenkwalder C. Restless legs syndrome and periodic limb movements. Adv Neurol 2002; 89:145-151.
10. Hornyak M, Feige B, Riemann D, Voderholzer U. Periodic leg movements in sleep and periodic limb movement disorder: prevalence, clinical significance and treatment. Sleep Med Rev 2006; 10(3):169-177.
11. Zucconi M, Ferri R, Allen R, Baier PC, Bruni O, Chokroverty S et al. The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG). Sleep Med 2006; 7(2): 175-183.
12. Chesson AL, Jr., Wise M, Davila D, Johnson S, Littner M, Anderson WM et al. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 1999; 22(7):961-968.
13. Pollmacher T, Schulz H. Periodic leg movements (PLM): their relationship to sleep stages. Sleep 1993; 16(6):572-577.
14. Sforza E, Jouny C, Ibanez V. Time course of arousal response during periodic leg movements in patients with periodic leg movements and restless legs syndrome. Clin Neurophysiol 2003; 114(6):1116-1124.
15. Nicolas A, Lesperance P, Montplaisir J. Is excessive daytime sleepiness with periodic leg movements during sleep a specific diagnostic category? Eur Neurol 1998; 40(1):22-26.
16. Reutens S, Sachdev PS. Periodic limb movements and other movement disorders in sleep: neuropsychiatric dimensions. Int Rev Psychiatry 2005; 17(4):283-292.
17. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003; 4(2):121-132.
18. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology 2000; 54(5):1064-1068.
19. Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 2004; 5(3):237-246.
20. Phillips B, HeningW, Britz P, Mannino D. Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest 2006; 129(1):76-80.
21. Sevim S, Dogu O, Camdeviren H, Bugdayci R, Sasmaz T, Kaleagasi H et al. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology 2003; 61(11): 1562-1569.
22. Abetz L, Arbuckle R, Allen RP, Mavraki E, Kirsch J. The reliability, validity and responsiveness of the Restless Legs Syndrome Quality of Life questionnaire (RLSQoL) in a trial population. Health Qual Life Outcomes 2005; 3:79.
23. McCrink L, Allen RP, Wolowacz S, Sherrill B, Connolly M, Kirsch J. Predictors of health-related quality of life in sufferers with restless legs syndrome: a multi-national study. Sleep Med 2007; 8(1):73-83.
24. Jenkinson C, Wright L, Coulter A. The SF 36 health survey questionnaire.if used within its limits. BMJ 1993; 307(6901):449.
25. Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, Bell TJ et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005; 165(11): 1286-1292.
26. Lopes LA, Lins CM, Adeodato VG, Quental DP, de Bruin PF, Montenegro RM, Jr. et al. Restless legs syndrome and quality of sleep in type 2 diabetes. Diabetes Care 2005; 28(11): 2633-2636.
27. Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004; 164(2):196-202.
28. Abetz L, Vallow SM, Kirsch J, Allen RP, Washburn T, Earley CJ. Validation of the Restless Legs Syndrome Quality of Life questionnaire. Value Health 2005; 8(2):157-167.
29. Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review. Sleep 1999; 22(7):970-999.
30. Trenkwalder C, Hundemer HP, Lledo A, Swieca J, Polo O, Wetter TC et al. Efficacy of pergolide in treatment of restless legs syndrome: The PEARLS Study. Neurology 2004; 62(8): 1391-1397.
31. Oertel WH, Benes H, Bodenschatz R, Peglau I, Warmuth R, Happe S et al. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR). Neurology 2006; 67(6):1040-1046.
32. Stiasny K, Wetter TC, Winkelmann J, Brandenburg U, Penzel T, Rubin M et al. Long-Term effects of pergolide in the treatment of restless legs syndrome. Neurology 2001; 56(10):1399-1402.
33. Trenkwalder C. The weight of evidence for ropinirole in restless legs syndrome. Eur J Neurol 2006; 13(Suppl 3):21-30.
34. Montplaisir J, Karrasch J, Haan J, Volc D. Ropinirole is effective in the long-Term management of restless legs syndrome: a randomized controlled trial. Mov Disord 2006; 21(10): 1627-1635.
35. Trenkwalder C, Garcia-Borreguero D, Montagna P, Lainey E, de Weerd AW, Tidswell P et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 2004; 75(1):92-97.
36. Walters AS, Ondo WG, Dreykluft T, Grunstein R, Lee D, Sethi K. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord 2004; 19(12):1414-1423.
37. Winkelman JW, Sethi KD, Kushida CA, Becker PM, Koester J, Cappola JJ et al. Efficacy and safety of pramipexole in restless legs syndrome. Neurology 2006; 67(6):1034-1039.
38. Partinen M, Hirvonen K, Jama L, Alakuijala A, Hublin C, Tamminen I et al. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study-The PRELUDE study. Sleep Med 2006; 7(5):407-417.
39. Allen RP. Restless legs syndrome effects on quality of life. In: Ondo WG, editor. Restless Legs Syndrome Diagnosis and Treatment. New York: Informa Healthcare, 2007: 199-203.
40. Trenkwalder C, Stiasny-Kolster K, Kupsch A, Oertel WH, Koester J, Reess J. Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome. Mov Disord 2006; 21(9):1404-1410.